Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 11/2008

01-09-2008 | Original Article

Two-year outcomes in primary THA in obese male veterans administration medical center patients

Authors: James A. Grant, Nicholas Viens, Michael P. Bolognesi, Steven A. Olson, Chad E. Cook

Published in: Rheumatology International | Issue 11/2008

Login to get access

Abstract

The objective of this study was to examine the influence of obesity on the rate of infection, dislocation, and overall complications in a group of male patients undergoing primary total hip arthroplasty (THA). The study involved a retrospective review of the association of body mass index (BMI) and dislocation, infection, and complications on 255 consecutive male patients who received a THA. BMI of 40 and greater had significantly more dislocations and approached significance for infections. The present study suggests that the risk of infection and dislocation increases only in highly obese males (BMI > 40) in contrast to other studies that have reported a higher risk infection, dislocation, and complications with a BMI of obesity in females (BMI > 30).
Literature
1.
Korner JJ, Eberle MA (2001) An update on the science and therapy of obesity and its relationship to osteoarthritis. Curr Rheumatol Rep 3:101–106PubMedCrossRef
2.
Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288:1723–1727PubMedCrossRef
3.
4.
Böstman OM (1994) Prevalence of obesity among patients admitted for elective orthopaedic surgery. Int J Obes 18:709–713
5.
Felson DT, Zhang Y (1998) An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 41:1343–1355PubMedCrossRef
6.
Karlson EW, Mandl LA, Aweh GN, Sangha O, Liang MH, Grodstein F (2003) Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors. Am J Med 114:93–98PubMedCrossRef
7.
Flugsrud GB, Nordsletten L, Espehaug B, Havelin LI, Engeland A, Meyer HE (2006) The impact of body mass index on later total hip arthroplasty for primary osteoarthritis: a cohort study in 1.2 million persons. Arthritis Rheum 54:802–807PubMedCrossRef
8.
Ibrahim T, Hobson S, Beiri A, Esler CN (2005) No influence of body mass index on early outcome following total hip arthroplasty. Int Orthop 29:359–361PubMedCrossRef
9.
Jain NB et al (2005) Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res 435:232–238PubMedCrossRef
10.
Jibodh SR, Gurkan I, Wenz JF (2004) In-hospital outcome and resource use in hip arthroplasty: influence of body mass. Orthopedics 27:594–601PubMed
11.
Lübbeke A, Stern R, Garavaglia G, Zurcher L, Hoffmeyer P (2007) Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum 57:327–334PubMedCrossRef
12.
Dominick KL, Golightly YM, Jackson GL (2006) Arthritis prevalence and symptoms among US non-veterans, veterans, and veterans receiving Department of Veterans Affairs Healthcare. J Rheumatol 33:348–354PubMed
13.
Heck DA, Maar DC, Lowdermilk GA, Kalasinski LA, Mesko JW (1992) Comparative analysis of total knee arthroplasty in two health care delivery systems. J Arthroplasty 7:93–100PubMedCrossRef
14.
Woolson ST, Rahimtoola ZO (1999) Risk factors for dislocation during the first 3 months after primary total hip replacement. J Arthroplasty 14:662–668PubMedCrossRef
15.
Paterno SA, Lachiewicz PF, Kelley SS (1997) The influence of patient-related factors and the position of the acetabular component on the rate of dislocation after total hip replacement. J bone Joint Surg Am 79:1202–1210PubMed
16.
Morrey BF (1992) Instability after total hip arthroplasty. Orthop Clin North Am 23:237–248PubMed
17.
Fackler CD, Poss R (1980) Dislocation in total hip arthroplasties. Clin Orthop 151:169–178PubMed
18.
Woo RYG, Morrey BF (1982) Dislocations after total hip arthroplasty. J Bone Joint Surg Am 63:214–218
19.
Ali Khan MA, Brakenbury PH, Reynolds IS (1981) Dislocation following total hip replacement. J Bone Joint Surg Br 63-B:214–218PubMed
20.
Hedlundh U, Ahnfelt L, Hybbinette CH, Weckstrom J, Fredin H (1996) Surgical experience related to dislocations after total hip arthroplasty. J Bone Joint Surg Br 78:206–209PubMed
21.
Kwon MS et al (2006) Does surgical approach affect total hip arthroplasty dislocation rates? Clin Orthop Relat Res 447:34–38PubMedCrossRef
22.
Soong M, Rubash HE, Macaulay W (2004) Dislocation after total hip arthroplasty. J Am Acad Orthop Surg 12:314–321PubMed
23.
Hulens M, Vansant G, Lysens R, Claessens AL, Muls E, Brumagne S (2001) Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach. Int J Obes 25:676–681CrossRef
24.
Vilar-Compte D, Mohar A, Sandoval S, de la Rosa M, Gordillo P, Volkow P (2000) Surgical site infections at the National Cancer Institute in Mexico: a case-control study. Am J Infect Control 28:14–20PubMedCrossRef
25.
Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE (2007) Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 89:33–38PubMedCrossRef
26.
Namba RS, Paxton L, Fithian DC, Stone ML (2005) Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty 20:46–50PubMedCrossRef
27.
Perka C, Labs K, Muschik M, Buttgereit F (2000) The influence of obesity on perioperative morbidity and mortality in revision total hip arthroplasty. Arch Orthop Trauma Surg 120:267–271PubMedCrossRef
28.
Perka C, Paul C, Matziolis G (2004) [Factors influencing perioperative morbidity and mortality in primary hip arthroplasty]. Der Orthopäde 33:715–720PubMed
29.
Lehman DE, Capello WN, Feinberg JR (1994) Total hip arthroplasty without cement in obese patients. A minimum two-year clinical and radiographic follow-up study. J Bone Joint Surg Am 76:854–862PubMed
30.
Jiganti JG, Goldstein WM, Williams CS (1993) A comparison of the perioperative morbidity in total joint arthroplasty in the obese and nonobese patient. Clin Orthop Relat Res 289:175–179PubMed
Metadata
Title
Two-year outcomes in primary THA in obese male veterans administration medical center patients
Authors
James A. Grant
Nicholas Viens
Michael P. Bolognesi
Steven A. Olson
Chad E. Cook
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0575-y

Other articles of this Issue 11/2008

Rheumatology International 11/2008 Go to the issue

Original Article

Are individuals with severe haemophilia A prone to reduced bone density?

Original Article

Musculoskeletal affections among kidney recipients: prevalence and risk predictors

Original Article

Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis

Original Article

Association between ‘interleukin’ 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement

Letter to the Editor

The single nucleotide polymorphisms of matrix metalloproteinase-1 in patients with systemic sclerosis

Letter to the Editor

Systemic lupus erythematosus, celiac disease and antiphospholipid antibody syndrome: a rare association

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits